Public Comments on Guidance For Determining Subject Matter Eligibility Of Claims Reciting Or Involving Laws of Nature, Natural Phenomena, & Natural Products (period for comment ends 31JUL2014)

Members of the public have been invited to submit written comments that present their interpretation of the impact of relevant Supreme Court precedent on the complex legal and technical issues involved in subject matter eligibility analyses during patent examination of claims reciting or involving laws of nature, natural phenomena, and natural products. The Office would like for members of the public who believe that the Supreme Court decisions could be implemented in an alternative manner from the approach taken in the Guidance to submit written comments presenting their alternative approach and the legal rationale for the alternative. The public is also invited to suggest additional examples for use by the Office to create a more complete picture of the impact of Supreme Court precedent on subject matter eligibility, and to provide comments on the subject matter eligibility of particular claims, including the sample claims discussed at the 2014 BIO International Convention.

Please submit your written comments on the Guidance by July 31, 2014, to the Guidance Mailbox.

--------------------------------------------------------------------------------

Please note that the following documents are posted as originally received but may contain artifacts of scanning, OCR, and document format conversion for presentation on the USPTO.gov website.

A. Intellectual Property Organizations and other Associations

B. Government Agencies

C. Academic and Research Institutions

D. Law Firms

E. Companies

F. Individuals

Received after August 1, 2014

  • Coalition for 21st Century Medicine (2014Aug06)
  • Joint Comment (2014Oct14)
    • Biotechnology Industry Organization
    • Coalition for 21st Century Medicine
    • GlaxoSmithKline
    • Novartis AG
    • Novo Nordisk Inc.
    • PharmaMar S.A.
    • Verenium Corporation
    • And in their individual capacity:
      • Nancy J. Linck, Partner, Rothwell Figg Ernst & Manbeck PC
      • Gladys H. Monroy, Senior Partner, Morrison & Foerster LLP
      • Kate H. Murashige, Senior Partner, Morrison & Foerster LLP
      • Kenneth H. Sonnenfeld, Partner, King & Spalding LLP
      • Suzannah K. Sundby, Partner, Canady & Lortz LLP
      • Warren D. Woessner, Founding Shareholder, Schwegman Lundberg Woessner PA
  • Joint Comment (2014Oct17)
    • Association of American Universities (AAU)
    • American Council on Education (ACE)
    • Association of American Medical Colleges (AAMC)
    • Association of Public and Land-grant Universities (APLU)
    • Association of University Technology Managers (AUTM)
    • Council on Governmental Relations (COGR)
  • PhRMA (2014Oct29)